Fig. 8.
![Fig. 8. Flow cytometry analysis of recombinant Oeaalloantigen. / (A) Binding of non-LIBS mAb Gi5 to stable transfectants expressing Pro33 (Oea [+]; black curve) and Pro33 ΔLys611 (Oea −; gray). (B) Binding of anti-LIBS mAb D3 to both stable transfectants in the presence of RGEW or RGDW peptides. (C) Binding of ligand-mimetic mAb PAC-1 to untreated and DTT-treated “activated” transfectants.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/99/4/10.1182_blood.v99.4.1205/6/h80422165008.jpeg?Expires=1736054664&Signature=Zv-geqR9i0T513EGgFIdKB6IK~8j5X5B9SdUM8KTHXh9t0kywZljLdIOj4ckvoX91wmmABl2Jx4J~Bxh7oPAK0USa8PHvdh5HRjH7~sdjGuk74H~2DiVsaGfV7e-TLi14HKEcnhGOtyAt45w6ssIo0MQfimBnwyRzjRX0wtN08NpnW6Fq1zNqAN0IkDSSyFTkvvDWbnbBgWTLpSUJ84h16ls9BAWpUBQ831YJ7I55r4NCKxbXjVbfqeUYh6Xg5v2Zw7Xqd327vb6lCXnWELv7NZW7IXy2yuc4o4Jg5uT6WRwOeWbHFGtt~dWO1GuLmkrBgevZ37KV-lr5pbiioTnUA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Flow cytometry analysis of recombinant Oeaalloantigen.
(A) Binding of non-LIBS mAb Gi5 to stable transfectants expressing Pro33 (Oea [+]; black curve) and Pro33 ΔLys611 (Oea −; gray). (B) Binding of anti-LIBS mAb D3 to both stable transfectants in the presence of RGEW or RGDW peptides. (C) Binding of ligand-mimetic mAb PAC-1 to untreated and DTT-treated “activated” transfectants.
